Method:
We describe the incompletely penetrant and variably expressed clinical phenotype of a patient of Caribbean descent with CTLA-4 HI, and his 4 related family members (Family pedigree, clinical presentation and genetic defect as depicted in Figure 1A-C). The study was approved by the institutional IRB. The informed consents were obtained as per the IRB guidelines.